Cargando...
An analysis of common ethical justifications for compassionate use programs for experimental drugs
BACKGROUND: When a new intervention or drug is developed, this has to pass through various phases of clinical testing before it achieves market approval, which can take many years. This raises an issue for drugs which could benefit terminally ill patients. These patients might set their hopes on the...
Gardado en:
| Publicado en: | BMC Med Ethics |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069844/ https://ncbi.nlm.nih.gov/pubmed/27756370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-016-0145-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|